Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $92000.0.

  • Treace Medical Concepts' Other Operating Expenses rose 36000.0% to $92000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $462000.0, marking a year-over-year increase of 5298.01%. This contributed to the annual value of $324000.0 for FY2024, which is 526.32% down from last year.
  • As of Q3 2025, Treace Medical Concepts' Other Operating Expenses stood at $92000.0, which was up 36000.0% from $122000.0 recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Other Operating Expenses high stood at $23.3 million for Q4 2021, and its period low was -$357000.0 during Q4 2022.
  • For the 5-year period, Treace Medical Concepts' Other Operating Expenses averaged around $3.5 million, with its median value being $96000.0 (2023).
  • In the last 5 years, Treace Medical Concepts' Other Operating Expenses plummeted by 10153.46% in 2022 and then soared by 630000.0% in 2023.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Other Operating Expenses stood at $23.3 million in 2021, then crashed by 101.53% to -$357000.0 in 2022, then surged by 126.89% to $96000.0 in 2023, then increased by 22.92% to $118000.0 in 2024, then fell by 22.03% to $92000.0 in 2025.
  • Its last three reported values are $92000.0 in Q3 2025, $122000.0 for Q2 2025, and $130000.0 during Q1 2025.